Florian Resch

We automate virtual world creation | Unlocking the 3D bottleneck in autonomous mobility

Syntropic is a clinical stage medical device company developing new technologies that enhance the brain’s neuroplasticity, allowing for the treatment of psychiatric disorders and the improvement of cognition.

Infrared City is a platform for intelligent and resilient design powered by Artificial Intelligence. We make complex environmental simulations accessible and understandable for all stakeholders of the built environment. Our state-of-the-art machine learning models provide real-time feedback on the performance of design proposals and can guide climate informed decisions at every step of the process. Infrared City currently provides feedback on solar, sunlight and wind performance. For more information, please visit www.infrared.city

🌊 Autonomous underwater inspections. Smarter. Safer. Greener. At Subdron, we provide high-resolution, repeatable inspections of port walls, ship hulls, and underwater infrastructure ⚓. Our advanced autonomous drones operate even in zero visibility, delivering precise 3D digital twins for better maintenance planning and reduced downtime. By enabling predictive maintenance and supporting sustainable asset management, we help our clients improve efficiency and reduce CO₂ emission - protecting both assets and the oceans 🌍. #UnderwaterTechnology #MaritimeInnovation #Sustainability

ReCatalyst is an EU-level recognized Start-up company and Slovenian Start-up-of-the-year in 2023, which develops and markets services in the field of nanotechnology materials. The company is currently focused on the development and commercialization of next-gen platinum-based catalyst composites for the use in hydrogen fuel cells and will expand its catalyst production platform also to other related areas for decarbonization of the energy and transport sectors such as water electrolysis as well as other Power to X applications. The company has established development collaborations with some of the most reputable companies in the field in five of the G7 economies and is supported by the prestigious European EIC Transition financing, as well as a EUR 1.7M investment from international investors.

As a spin-off of the TU Vienna, we develop software that regularly transforms energy data into actionable tasks. As a result, our customers reduce up to 20 percent of their annual energy costs. nista makes savings potential visible and helps to reduce C0₂ emissions in the long term. Our mission is to leverage the power of data to tackle the energy transition.

CellEctric is decoding the software of life. Our technology allows the continuous processing of cell suspensions while selectively permeabilizing or disintegrating targeted subsets by electromagnetic manipulation. Our competitive advantage is based on the exclusion of unspecific interference by a patented dielectric filter technology along our electrodes. The outcome features unrivalled specificity and throughput. Fast, automated and selective.

contextflow is your comprehensive solution for all things chest CT: lung cancer, ILD and COPD. Our computer-aided detection system ADVANCE Chest CT offers lung nodule detection & tracking of changes over time, quantitative and qualitative analysis of 8 key image patterns, and 3D image search for 19 image patterns. By integrating new technology from partner RevealDx, nodules can be further characterized, detecting lung cancer earlier and reducing costs (JACR 9/22). contextflow ADVANCE Chest CT includes a TIMELINE feature that even quantifies and visualizes nodules over time, allowing physicians to follow treatment progress easily and efficiently. Fully integrated into the radiologists workflow, our preliminary research shows average reading time is 31% shorter when contextflow SEARCH is available for use (European Radiology July 2022). Coming soon in 2023: incidental pulmonary embolism. contextflow is a spin-off of the Medical University of Vienna (MUW), Technical University of Vienna (TU) and European research project KHRESMOI. Founded by myself and 3 other AI and medical imaging experts in July 2016, we were awarded the distinction of Most Promising Startup by the BCS Search Industry and received the Digital Innovation Award by the Austrian Federal Ministry of Education, Science and Research that same year. In 2018, we were selected as one of 19 startups out of 700+ applications to participate in the Philips HealthWorks accelerator program and were named Top HealthTech Company - Austria for the 2019 Central Eastern Startup Awards. Forbes DACH listed us as one of the top AI30 startups in 2020, and the Austrian Chamber of Commerce named us a Born Global Champion in 2021. Twitter: @contextflow_rad Youtube: https://www.youtube.com/channel/UCTvdkGwlHio0vKfhvqQT_UA Sign up for our newsletter: contextflow.ac-page.com/newsletter-sign-up

Sarcura develops a machine platform for the large scale, industrial manufacturing of personalized cell therapies. Our target is to scale global manufacturing capacity for these life saving, patient specific cancer treatments from thousands of doses per year to hundreds of thousands, cost effective and safe for a all patients. We will transform existing manufacturing paradigms by using semiconductor technology to bring bioprocess control to cellular level. MINIATURIZE. AUTOMATE. INTEGRATE.

Welcome to your expert operating system for supply chain risk. Combining Tier-N transparency, supplier mapping, ESG standards and due diligence compliance makes Prewave a unique software for supply chain management. Achieve resilience, transparency and sustainability today 🇪🇺 ---- * Technical University of Vienna Spin-off * TUW i2c incubated * Supported by AWS - Austria Wirtschaftsservice

Are you tired of outdated asset management methods that drain your budget? Its time to take control, boost efficiency, and cut costs with the ToolSense Asset Operations Platform. 𝙒𝙝𝙮 𝙘𝙝𝙤𝙤𝙨𝙚 𝙏𝙤𝙤𝙡𝙎𝙚𝙣𝙨𝙚: ToolSense is your key to streamlining your day-to-day operations. Its tailor-made for teams handling operations, maintenance, and repairs in various industries, such as construction, facility management, aviation, healthcare, and hospitality. 𝙔𝙤𝙪 𝙘𝙖𝙣 𝙪𝙨𝙚 𝙤𝙪𝙧 𝙪𝙨𝙚𝙧-𝙛𝙧𝙞𝙚𝙣𝙙𝙡𝙮 𝙥𝙡𝙖𝙩𝙛𝙤𝙧𝙢 𝙩𝙤 𝙚𝙖𝙨𝙞𝙡𝙮: ✅ Keep an eye on your assets ✅ Use real-time data from your assets, machines, vehicles, and tools ✅ Simplify maintenance and safety tasks ✅ Make your daily operations a breeze 𝙔𝙤𝙪𝙧 𝘼𝙙𝙫𝙖𝙣𝙩𝙖𝙜𝙚𝙨 𝙬𝙞𝙩𝙝 𝙏𝙤𝙤𝙡𝙎𝙚𝙣𝙨𝙚: ⭐ Slash Unplanned Downtime by 75%: No more surprise breakdowns. ⭐ Save 20% on Maintenance Costs: Spend less on upkeep, repairs and parts. ⭐ Boost Efficiency: Meet compliance rules and keep your frontline workers safe. Still stuck with spreadsheets and paper-based processes? Its time to go digital with ToolSense. 𝙒𝙝𝙖𝙩 𝙒𝙚 𝘾𝙖𝙣 𝙃𝙚𝙡𝙥 𝙔𝙤𝙪 𝘿𝙞𝙜𝙞𝙩𝙞𝙯𝙚: ✔️ Asset Management ✔️ Connecting your Fleet, Machines, and Assets with IoT Hardware ✔️ Maintenance Management and Supplier Integration ✔️ Preventive and Predictive Maintenance ✔️ Asset Lifecycle Management Workflows ✔️ Safety and Inspection Procedures ✔️ Work Order Management ✔️ Asset Scheduling and Delivery Notes ✔️ Vehicle Management and GPS Route Tracking ✔️ Parts and Inventory Management ✔️ Integration with ERP, CRM, and 3rd Party IoT Systems Join the ranks of our satisfied clients, including ISS, STIHL, JLL, Compass Group, SPIE, Vinci, and many more. Discover how ToolSense can transform your operations at www.toolsense.io. Dont let outdated asset management practices lose you money. Choose ToolSense and embrace a more efficient, cost-effective, and compliant way of managing your assets.

Miracor Medical SA is a European medical device company dedicated to improve clinical outcome of patients with impaired cardiac function. Miracor develops and studies the PiCSO® (Pressure-controlled intermittent Coronary Sinus Occlusion) Impulse System, which is used as an adjunctive technique during the primary PCI procedure for acute myocardial infarction patients. PiCSO therapy seeks to improve coronary microvascular function to reduce infarct size and salvage myocardium, thereby improving outcomes of ST-elevation myocardial infarction (STEMI) patients. Recent Clinical Studies have successfully demonstrated the safety and positive effects of PiCSO on coronary microvascular function and infarct size reduction in STEMi patients. The company is conducting further clinical trials in Europe and plans to initiate a US IDE randomized controlled trial in 2023. Miracor has won several innovation awards and completed financing rounds raising venture capital and public funding. The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners.

PlanRadar is an award-winning digital SaaS platform for documentation, task management and communication in construction and real estate projects. We operate across the globe, currently in over 75 markets. We service all markets across real estate and construction, adding value to every person involved in the building lifecycle, from contractors and engineers to property managers and owners. Our platform digitises all daily processes and communication, enabling time savings, cost savings and allowing projects to be completed to a higher quality. Everyday we help professionals drive efficiencies and increase their project success by streamlining the way they work and providing real-time access to valuable project data. Today, there are over 120,000 users of the platform experiencing huge cost and time savings with the help of PlanRadar. PlanRadar is currently available in 20 languages, and can be used across all IOS, Windows and Android devices.

meo ENERGY digitalisiert alle Energieflüsse in Gebäuden: Power & ActiveHeat - Energiemanagement für die Profis der Energietechnik und mehr Transparenz und Effizienz für Immobilienverwalter. meo bringt intelligente Energie für den Klimaschutz.

Themis Bioscience is an international biotech company that successfully develops vaccines against emerging and specialist indications. Exploiting the full potential of our proprietary Themaxyn® platform we are able to identify and rapidly advance vaccine candidates at various stages of development. Based on a well-proven base technology, the Themaxyn® platform offers both, an excellent safety profile and a validated manufacturing process. Themis Bioscience was founded in 2009 by a group of internationally renowned vaccine and biotech executives in Vienna, Austria. In 2014 Themis successfully completed a phase I clinical trial with our Chikungunya vaccine in Austria. Themis continues to head the race for preventing emerging infectious diseases and started a phase II clinical trial with our Chikungunya vaccine in 2016 and a phase I clinical trial with our Zika vaccine in 2017.

We automate virtual world creation | Unlocking the 3D bottleneck in autonomous mobility

Syntropic is a clinical stage medical device company developing new technologies that enhance the brain’s neuroplasticity, allowing for the treatment of psychiatric disorders and the improvement of cognition.

Infrared City is a platform for intelligent and resilient design powered by Artificial Intelligence. We make complex environmental simulations accessible and understandable for all stakeholders of the built environment. Our state-of-the-art machine learning models provide real-time feedback on the performance of design proposals and can guide climate informed decisions at every step of the process. Infrared City currently provides feedback on solar, sunlight and wind performance. For more information, please visit www.infrared.city

🌊 Autonomous underwater inspections. Smarter. Safer. Greener. At Subdron, we provide high-resolution, repeatable inspections of port walls, ship hulls, and underwater infrastructure ⚓. Our advanced autonomous drones operate even in zero visibility, delivering precise 3D digital twins for better maintenance planning and reduced downtime. By enabling predictive maintenance and supporting sustainable asset management, we help our clients improve efficiency and reduce CO₂ emission - protecting both assets and the oceans 🌍. #UnderwaterTechnology #MaritimeInnovation #Sustainability

ReCatalyst is an EU-level recognized Start-up company and Slovenian Start-up-of-the-year in 2023, which develops and markets services in the field of nanotechnology materials. The company is currently focused on the development and commercialization of next-gen platinum-based catalyst composites for the use in hydrogen fuel cells and will expand its catalyst production platform also to other related areas for decarbonization of the energy and transport sectors such as water electrolysis as well as other Power to X applications. The company has established development collaborations with some of the most reputable companies in the field in five of the G7 economies and is supported by the prestigious European EIC Transition financing, as well as a EUR 1.7M investment from international investors.